July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Characterisation of Retinal Degeneration in Idh3a Mutant Mice
Author Affiliations & Notes
  • Amy Findlay
    University of Edinburgh, MRC Human Genetics Unit, Edinburgh, United Kingdom
  • Klara Novakova
    University of Edinburgh, MRC Human Genetics Unit, Edinburgh, United Kingdom
  • Lisa Mckie
    University of Edinburgh, MRC Human Genetics Unit, Edinburgh, United Kingdom
  • Roderick Carter
    QMRI, University of Edinburgh, Edinburgh, United Kingdom
  • Paul Potter
    MRC Harwell, Oxford, United Kingdom
  • Ian Jackson
    University of Edinburgh, MRC Human Genetics Unit, Edinburgh, United Kingdom
  • Footnotes
    Commercial Relationships   Amy Findlay, None; Klara Novakova, None; Lisa Mckie, None; Roderick Carter, None; Paul Potter, None; Ian Jackson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 973. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Amy Findlay, Klara Novakova, Lisa Mckie, Roderick Carter, Paul Potter, Ian Jackson; Characterisation of Retinal Degeneration in Idh3a Mutant Mice. Invest. Ophthalmol. Vis. Sci. 2018;59(9):973.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Isocitrate dehydrogenase (IDH) is an enzyme required for the production of α-ketoglutarate from isocitrate. IDH3 generates the NADH used in the mitochondria for ATP production, and is a tetramer made up of two α, a β and a γ subunit. Loss of function and missense mutations in both IDH3A and IDH3B have previously been implicated in families exhibiting retinal degeneration. A child homozygous for an IDH3A mutation has also been described with severe neurological disease, including retinal degeneration. Using mouse models we have investigated the role of IDH3 in retinal disease and mitochondrial function.

Methods : Loss of function mouse models were developed using CRISPR/cas-9 technology. Electroretinogram analysis was utilised to track the progress of the retinal degeneration in mouse models; followed by immuno fluorescence and histology to pin point the onset and quantify cell loss during. Mitochondrial functional analysis was done using Agilent Seahorse technology on mouse embryonic fibroblast cells, cultured from mutant lines.

Results : We identified mice with late-onset retinal degeneration in a screen of ageing mice carrying ENU-induced mutations. Low-resolution mapping followed by whole genome sequencing found a missense mutation in the α-subunit gene, Idh3a (E229K). Mice homozygous for this mutation, exhibit signs of retinal stress, indicated by GFAP staining, as early as 3 months and photoreceptor degeneration from 7 months, but, as with the human IDH3A mutations, no other tissues appear to be affected. We used CRISPR/Cas9 technology to produce a knockout of Idh3a and find that homozygous mice do not survive past early embryogenesis. Idh3aE229K/- compound heterozygous mutants exhibit a more severe retinal degeneration when compared to Idh3aE229K/E229K, showing severely deteriorated ERG responses by 2 months, accompanied by photoreceptor loss and GFAP staining. Analysis of mitochondrial function, using Agilent Seahorse technology, on MEF mutant cell lines highlighted a reduction in both mitochondrial maximal respiration and reserve capacity levels in both Idh3aE229K/E229K and Idh3aE229K/- cells.

Conclusions : It has been previously reported that the retina operates with a limited mitochondrial reserve capacity and we suggest that this, in combination with the reduced reserve capacity in mutants, explains the degenerative phenotype observed

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×